Loading stock data…
$2.60-0.05 (-1.89%)
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally.
Apyx Medical Corporation in the Healthcare sector is trading at $2.60 with a market capitalization of $129M. Wall Street consensus targets $6.50 (6 analysts), implying a +150.0% move over the next 12 months. The stock is currently near its 52-week low of $2.32, remaining 29.2% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $13.88M↑ | $12.49M↓ | $19.16M↑ | $12.88M↑ | $11.37M |
| Gross Profit | $8.87M↑ | $7.92M↓ | $12.00M↑ | $8.30M↑ | $7.08M |
| Operating Income | -$1.81M↓ | -$911,000↓ | $11,000↑ | -$832,000↑ | -$2.57M |
| Net Income | -$3.24M↓ | -$2.11M↓ | -$1.30M↑ | -$1.98M↑ | -$3.78M |
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics ...